Treatment of neovascular age-related macular degeneration: Current therapies

References

• HaabOErkrankungen der macula LuteaZentralbl Augenheilkd18859384391
   Google Scholar
• NettleshipECentral areolar choroidal atrophyTrans Ophthalmol Soc U K18844165166
   Google Scholar
• LeibowitzHMKruegerDAMaunderRAThe Framingham Eye Study monograph; an ophthalmological study of cataract, glaucoma, diabetic retinopathy, macular degeneration and visual acuity in a general population of 2631 adults 1973–75Surv Ophthalmol198024Suppl3356107444756
   PubMedGoogle Scholar
• FriedmanDSO’ColmainBJMuñozBEye Diseases Prevalence Research GroupPrevalence of age-related macular degeneration in the United StatesArch Ophthalmol200412256457215078675
   PubMed Web of Science ®Google Scholar
• CongdonNO’ColmainBKlaverCCthe Eye Diseases Prevalence Research GroupCauses and prevalence of visual impairment among adults in the United StatesArch Ophthalmol200412247748515078664
   PubMed Web of Science ®Google Scholar
• AugoodCAVingerlingJRde JongPTVMPrevalence of age-related maculopathy in older Europeans. The European Eye Study (EurEye)Arch Ophthalmol200612452953516606879
   PubMed Web of Science ®Google Scholar
• BirdACBresslerNMBresslerSBAn international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study GroupSurv Ophthalmol1995393673747604360
   PubMed Web of Science ®Google Scholar
• Preliminary report on effects of photocoagulation therapy. The Diabetic Retinopathy Study Research GroupAm J Ophthalmol197681383396944535
   PubMed Web of Science ®Google Scholar
• CoscasGSoubraneGPhotocoagulation des neo vaisseaux sous-retiniens dans la degenerescence maculaire senile par laser a argon; resultats de l’etude randomisee de 60 casBull Soc Ophtalmol Fr198294149154
   Google Scholar
• Argon laser photocoagulation for senile macular degeneration. Results of a randomized clinical trialArch Ophthalmol19821009129187046707
   PubMed Web of Science ®Google Scholar
• Treatment of senile disciform macular degeneration: a single-blind randomised trial by argon laser photocoagulation. The Moorfields Macular Study GroupBr J Ophthalmol1982667457536184070
   PubMed Web of Science ®Google Scholar
• Persistent and recurrent neovascularization after krypton laser photocoagulation for neovascular lesions of age-related macular degeneration. Macular Photocoagulation Study GroupArch Ophthamol1990108825831
   PubMed Web of Science ®Google Scholar
• FreundKBYannuzziLASorensonJAAge-related macular degeneration and choroidal neovascularizationAm J Ophthalmol19931157867917685148
   PubMed Web of Science ®Google Scholar
• MöhleRGreenDMooreMAConstitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and plateletsPNAS1997946636689012841
   PubMed Web of Science ®Google Scholar
• CiullaTACriswellMHDanisRPIntravitreal triamcinolone acetonide inhibits choroidal neovascularization in a laser-treated rat modelArch Ophthalmol200111939940411231773
   PubMed Web of Science ®Google Scholar
• ChandlerDBRozakisGde JuanEJrThe effect of triamcinolone acetonide on a refined experimental model of proliferative vitreoretinopathyAm J Ophthalmol1985996866902409802
   PubMed Web of Science ®Google Scholar
• HidaTChandlerDArenaJEExperimental and clinical observations of the intraocular toxicity of commercial corticosteroid preparationsAm J Ophthalmol19861011901953753824
   PubMed Web of Science ®Google Scholar
• IshibashiTMikiKSorgenteNPattersonREffects of intravitreal administration of steroids on experimental subretinal neovascularization in the subhuman primateArch Ophthalmol19851037087112581536
   PubMed Web of Science ®Google Scholar
• ChallaJKGilliesMCPenfoldPLExudative macular degeneration and intravitreal triamcinolone: 18 month follow upAust N Z J Ophthalmol1998262772819843254
   PubMedGoogle Scholar
• PenfoldPLGyoryJFHunyorABExudative macular degeneration and intravitreal triamcinolone. A pilot studyAust N Z J Ophthalmol19952329329811980075
   PubMedGoogle Scholar
• DanisRPCiullaTAPrattLMIntravitreal triamcinolone aceotonide in exudative age-related macular degenerationRetina20002024425010872928
   PubMed Web of Science ®Google Scholar
• JonasJBAkkoyunIBuddeWMIntravitreal reinjection of triamcinolone for exudative age-related macular degenerationArch Ophthalmol200412221822214769599
   PubMed Web of Science ®Google Scholar
• GilliesMCSimpsonJMLuoWA randomized clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration: one-year resultsArch Ophthalmol200312166767312742844
   PubMed Web of Science ®Google Scholar
• JonasJBDegenringRFKreissigIIntraocular pressure elevation after intravitreal triamcinolone acetonide injectionOphthalmology200511259359815808249
   PubMed Web of Science ®Google Scholar
• RheeDJPeckREBelmontJIntraocular pressure alterations following intravitreal triamcinolone acetonideBr J Ophthalmol200690999100316597664
   PubMed Web of Science ®Google Scholar
• Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials – TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study GroupArch Ophthalmol19991171329134510532441
   PubMed Web of Science ®Google Scholar
• KaiserPKTreatment of Age-related Macular Degeneration with Photodynamic Therapy (TAP) Study GroupVerteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: 5-year results of two randomized clinical trials with an open-label extension: TAP report no. 8Graefes Arch Clin Exp Ophthalmol20062441132114216538452
   PubMed Web of Science ®Google Scholar
• Verteporfin In Photodynamic Therapy Study GroupVerteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization–verteporfin in photodynamic therapy report 2Am J Ophthalmol200113154156011336929
   PubMed Web of Science ®Google Scholar
• BlinderKJBradleySBresslerNMTreatment of Age-related Macular Degeneration with Photodynamic Therapy study group; Verteporfin in Photodynamic Therapy study groupEffect of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy for choroidal neovascularization secondary to age-related macular degeneration: TAP and VIP report no. 1Am J Ophthalmol200313640741812967792
   PubMed Web of Science ®Google Scholar
• AzabMBoyerDSBresslerNMVisudyne in Minimally Classic Choroidal Neovascularization Study GroupVerteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trialArch Ophthalmol200512344845715824216
   PubMed Web of Science ®Google Scholar
• KannanRZhangNSreekumarPGStimulation of apical and basolateral VEGF-A and VEGF-C secretion by oxidative stress in polarized retinal pigment epithelial cellsMol Vis2006121649165917200665
   PubMed Web of Science ®Google Scholar
• GragoudasESAdamisAPCunninghamETJrPegaptanib for neovascular age-related macular degenerationN Engl J Med20043512805281615625332
   PubMed Web of Science ®Google Scholar
• RichRMRosenfeldPJPuliafitoCAShort-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degenerationRetina20062649551116770255
   PubMed Web of Science ®Google Scholar
• SpaideRFLaudKFineHFIntravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degenerationRetina20062638339016603955
   PubMed Web of Science ®Google Scholar
• BashshurZFBazarbachiASchakalAIntravitreal bevacizumab for the management of choroidal neovascularization in age-related macular degenerationAm J Ophthalmol20061421916815245
   PubMed Web of Science ®Google Scholar
• RosenfeldPJBrownDMHeierJSRanibizumab for neovascular age-related macular degenerationN Engl J Med20063551419143117021318
   PubMed Web of Science ®Google Scholar
• BrownDMKaiserPKMichelsMRanibizumab versus verteporfin for neovascular age-related macular degenerationN Engl J Med20063551432144417021319
   PubMed Web of Science ®Google Scholar
• KaiserPKBrownDMZhangKRanibizumab for predominantly classic neovascular age-related macular degeneration: Subgroup analysis of first-year ANCHOR resultsAm J Ophthalmol200714485085717949673
   PubMed Web of Science ®Google Scholar
• RosenfeldPJHeierJSHantsbargerGShamsNTolerability and efficacy of multiple escalating doses of ranibizumab (Lucentis) for neovascular age-related macular degenerationOphthalmology200611362363216581423
   PubMed Web of Science ®Google Scholar
• SteinbrookRThe price of sight–ranibizumab, bevacizumab, and the treatment of macular degenerationN Engl J Med20063551409141217021315
   PubMed Web of Science ®Google Scholar
• FungAELalwaniGARosenfeldPJAn optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degenerationAm J Ophthalmol200714356658317386270
   PubMed Web of Science ®Google Scholar
• RegilloCDBrownDMAbrahamPRandomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER Study Year 1Am J Ophthalmol200814523924818222192
   PubMed Web of Science ®Google Scholar
• HeierJSthe ANCHOR Study GroupRanibizumab: Two-year ANCHOR Study resultsOral presentation. Retina Subspecialty Day, Annual Meeting of American Academy of OphthalmologyNew Orleans, USA2007
   Google Scholar
• PaoloLLessons Learned from the FOCUS TrialOral presentation. Retina Subspecialty Day, Annual Meeting of American Academy of OphthalmologyNew Orleans, USA2007
   Google Scholar
• ChiangAChangLKYuFPredictors of anti-VEGF-associated retinal pigment epithelial tear using FA and OCT analysisRetina2008714[Epub ahead of print].
   Web of Science ®Google Scholar
• AugustinAJPulsSOffermannITriple therapy for choroidal neovascularization due to age-related macular degeneration: verteporfin PDT, bevacizumab, and dexamethasoneRetina20072711314017218926
   PubMed Web of Science ®Google Scholar
• CallananDGUnpublished studyOral presentation. Retina Subspecialty Day, Annual Meeting of American Academy of OphthalmologyNew Orleans, USA2007
   Google Scholar
• Schmidt-ErfurthUWolfSPaper submitted to Archives of OphthalmologyOral presentation. Retina Subspecialty Day, Annual Meeting of American Academy of OphthalmologyNew Orleans, USA2007
   Google Scholar